Announcement: Primary aldosteronism: why screening for this overlooked cause of hypertension matters

ბოლო განახლება: 10/09/2026 04:41

ავტორი:

0 Min Read

Primary aldosteronism causes 5–15% of hypertension cases but remains underdiagnosed globally. A Nature Reviews Disease Primers review highlights improved screening protocols, diagnostic pathways, and treatment outcomes in this important but overlooked endocrine disorder. — Photo by Mikhail Nilov on Pexels (Pexels License)

1 min read|51 words

Primary aldosteronism causes 5–15% of hypertension globally but remains widely underdiagnosed. A new Nature Reviews Disease Primers review reveals why systematic screening matters, how to diagnose it accurately, and why distinguishing unilateral from bilateral disease determines whether surgery could cure it. Read the full analysis.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Primary aldosteronism: why screening for this overlooked cause of hypertension matters →

Share This Article

ავტორი:Prof. Giorgi Pkhakadze

Follow:

Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Announcement: Primary aldosteronism: why screening for this overlooked cause of hypertension matters

Submit Your Paper →

Nearly 2.7 million Malians lack timely access to antiretroviral therapy due to distance and supply-side barriers

Higher-dose primaquine halves P. vivax recurrence in Indonesia, but safety trade-offs emerge

Adverse Childhood Experiences in Rural India: Why Western Frameworks Fall Short

Submit Your Paper to GMJ

Company

You Might Also Like